Quris is an artificial intelligence innovator that is disrupting drug development. Its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. Quris is led by a track-record team of top scientists and strategic investors. Its first AI-based drug is now prepping for clinical testing.
Location: Israel, Tel Aviv
Employees: 11-50
Total raised: $18M
Investors 2
| Date | Name | Website |
| 17.05.2024 | BioVenture... | azbioventu... |
| - | Max Burger | maxburger.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.12.2022 | Seed | $9M | - |
| 18.10.2021 | - | $9M | - |
Mentions in press and media 9
| Date | Title | Description |
| 20.12.2022 | Quris Raises Additional $9M in Seed Funding | Quris, a Boston, MA and Tel Aviv, Israel-based an artificial intelligence (AI) provider, raised additional $9M in Seed funding. The round, which brought total seed round funding to $37M, was led by SoftBank Vision Fund 2, GlenRock Capital, ... |
| 20.12.2022 | AI-powered pharmaceutical drug testing startup Quris Technologies raises $9M in funding Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Join the commun... | Israeli pharmaceutical artificial intelligence startup Quris Technologies Ltd. said today it has secured an additional $9 million in seed funding, bringing its total amount raised to $37 million. The latest investment was led by SoftBank Vi... |
| 11.01.2022 | Farmland investing startup raises $40 million as venture capital keeps seeping out of Silicon Valley | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. When it was nearing 6 p.m. a week ago, I found it hard to take my eyes off the sky—the vivid pink... |
| 11.01.2022 | Quris Closes $28 Million in Seed Funding From Top Institutional Investors | BOSTON and TEL-AVIV, Israel, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced the final close of $28 million in seed funding – inclusive of the initial $... |
| 11.01.2022 | Quris Closes $28 Million in Seed Funding From Top Institutional Investors | Industry Strengthens Support for AI Innovator in Push to Close Essential Gaps in Drug Development as Company Prepares for Clinical Testing of the First Drug Developed via the Quris Platform BOSTON and TEL-AVIV, Israel, Jan. 11, 2022 (GLOBE ... |
| 01.11.2021 | Pharma startup Quris aims to use a ‘patient on a chip’ to target drug delivery | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Nobel Laureate, Aaron Ciechanover, is one of seve... |
| 01.11.2021 | Pharma startup Quris aims to use a ‘patient on a chip’ to target drug delivery | Nobel Laureate, Aaron Ciechanover, is one of several notable names behind pharma startup Quris. The company aims to bring together artificial intelligence, the industry’s vast knowledge of the human genome, and the concept of the “patient o... |
| 18.10.2021 | Israeli pharmaceutical AI startup Quris raises $9M and launches new platform Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Join the community that in... | Israeli pharmaceutical artificial intelligence startup Quris Technologies today announced $9 million in new funding and launched a clinical prediction AI platform to predict which drug candidates will safely work in humans. The seed round i... |
| - | Quris | “Quris AI is tackling the most impactful AI challenge of our time: Predicting which drug candidates will safely work in humans. Quris’s machine-learning bio-platform predicts which drug candidates will safely work in humans.” |